Dimercaprol and Alcohol/Food Interactions
There are 2 alcohol/food/lifestyle interactions with dimercaprol which include:
dimercaprol multivitamins with minerals
Major Drug Interaction
Dimercaprol can bind with certain metals such as iron and selenium, forming a complex that is toxic to the kidneys. Products containing iron or selenium should not be used during dimercaprol therapy. If you are currently receiving or have recently received multivitamin with minerals, let your doctor know before receiving treatment with dimercaprol. You may need to wait at least 24 hours after the last dose of dimercaprol before you can start or resume multivitamin with minerals. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
High Blood Pressure (Hypertension)
Moderate Potential Hazard, High plausibility
dimercaprol - hypertension
Dose-related increase in systolic and diastolic blood pressure, with or without accompanying tachycardia, is the most frequently reported adverse effect of dimercaprol therapy. Blood pressure may rise 15 to 30 minutes following injection and usually returns to normal within 2 hours. Therapy with dimercaprol should be administered cautiously in patients with hypertension. Clinical monitoring of blood pressure is recommended.
- "Product Information. BAL in Oil (dimercaprol)." Becton Dickinson, Franklin Lakes, NJ.
Dimercaprol drug interactions
There are 24 drug interactions with dimercaprol
Dimercaprol disease interactions
There are 5 disease interactions with dimercaprol which include:
More about dimercaprol
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|